Pulse Biosciences, Inc. Revenue 2020–2025
Pulse Biosciences, Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Pulse Biosciences, Inc. revenue for the quarter ending March 31, 2026 was 401000.
- Pulse Biosciences, Inc. revenue for the twelve months ending March 31, 2026 was 487000.
- Pulse Biosciences, Inc. annual revenue for 2025 was 350000.
- Pulse Biosciences, Inc. annual revenue for 2024 was 0.
- Pulse Biosciences, Inc. annual revenue for 2023 was 0, a 100.00% decrease from 2022.
- Pulse Biosciences, Inc. annual revenue for 2022 was 700000.
Pulse Biosciences, Inc. (PLSE) — Frequently Asked Questions
Pulse Biosciences, Inc. (PLSE) is a publicly traded US company. It has a market capitalization of $1.70B. In fiscal 2025 it reported revenue of $350,000 and net income of -$73M. Explore PLSE's stock price, financial statements, earnings history, margins and key ratios below.
What is Pulse Biosciences, Inc.'s market cap?
Pulse Biosciences, Inc. (PLSE) has a market capitalization of $1.70B.
What is the PLSE stock price?
PLSE trades at $24.99 (-3.03% on the day).
How much revenue does Pulse Biosciences, Inc. make?
Pulse Biosciences, Inc. reported revenue of $350,000 in fiscal 2025.
Is PLSE profitable?
In fiscal 2025, Pulse Biosciences, Inc. reported net income of -$73M.